Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation

Neurogenetics

Volumn 10, Issue 1, 2009, Pages 79-85

  Bartelt Kirbach, B ^a   Wuepping, M ^a   Dodrimont Lattke, M ^a   Kaufmann, D ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Neurofibroma; Neurofibromatosis type 1; NF1 microdeletion syndrome; NF1 modifying genes

Indexed keywords

NEUROFIBROMIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROFIBROMA; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CHROMOSOMES, HUMAN, PAIR 17; GENE DELETION; GENE EXPRESSION; HUMANS; LOSS OF HETEROZYGOSITY; NEUROFIBROMA; NEUROFIBROMATOSIS 1;

EID: 58649108765     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-008-0154-0     Document Type: Article

References (30)

1. SA Rasmussen JM Friedman 2000 NF1 gene and neurofibromatosis 1 Am J Epidemiol 151 33 40
2. DF Easton MA Ponder SM Huson BA Ponder 1993 An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes Am J Hum Genet 53 305 313
3. V Wiest I Eisenbarth C Schmegner W Krone G Assum 2003 Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers Hum Mutat 22 423 427 doi:10.1002/humu.10272
4. L Fishbein X Zhang LB Fisher H Li M Campbell-Thompson A Yachnis 2007 In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells Mol Carcinog 46 512 523 doi:10.1002/mc.20236
5. M Clementi S Boni I Mammi M Favarato R Tenconi 1996 Clinical application of genetic polymorphism in neurofibromatosis type 1 Ann Genet 39 92 96
6. MH Cnossen MN van der Est MH Breuning CJ van Asperen EJ Breslau-Siderius AT van der Ploeg 1997 Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1 Hum Mutat 9 458 464
7. SA Rasmussen SD Colman VT Ho CR Abernathy PH Arn L Weiss 1998 Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1 J Med Genet 35 468 471
8. L Kluwe R Siebert S Gesk RE Friedrich S Tinschert H Kehrer-Sawatzki 2004 Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene Hum Mutat 23 111 116 doi:10.1002/humu.10299
9. KA Mensink RP Ketterling HC Flynn RA Knudson NM Lindor BA Heese 2006 Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature J Med Genet 43 e8 doi:10.1136/jmg.2005.034256
10. DE Jenne S Tinschert MO Dorschner H Hameister K Stephens H Kehrer-Sawatzki 2003 Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse Genes Chromosomes Cancer 37 111 120 doi:10.1002/gcc.10206
11. T De Raedt H Brems C Lopez-Correa JR Vermeesch P Marynen E Legius 2004 Genomic organization and evolution of the NF1 microdeletion region Genomics 84 346 360 doi:10.1016/j.ygeno.2004.03.006
12. M Lagos-Quintana R Rauhut J Meyer A Borkhardt T Tuschl 2003 New microRNAs from mouse and human RNA 9 175 179 doi:10.1261/rna.2146903
13. I Bentwich A Avniel Y Karov R Aharonov S Gilad O Barad 2005 Identification of hundreds of conserved and nonconserved human microRNAs Nat Genet 37 766 770 doi:10.1038/ng1590
14. CC Lopez H Brems C Lazaro P Marynen E Legius 2000 Unequal meiotic crossover: a frequent cause of NF1 microdeletions Am J Hum Genet 66 1969 1974 doi:10.1086/302920
15. M Venturin P Guarnieri F Natacci M Stabile R Tenconi M Clementi 2004 Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2 J Med Genet 41 35 41 doi:10.1136/jmg.2003. 014761
16. M Venturin A Bentivegna R Moroni L Larizza P Riva 2005 Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion interval Ann Hum Genet 69 508 516 doi:10.1111/j.1529-8817.2005. 00203.x
17. J Douglas D Cilliers K Coleman K Tatton-Brown K Barker B Bernhard 2007 Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth Nat Genet 39 963 965 doi:10.1038/ng2083
18. VM Riccardi 2007 The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1 Neurosurg Focus 22 E3 doi:10.3171/foc.2007.22.6.4
19. FC Yang DA Ingram S Chen CM Hingtgen N Ratner KR Monk 2003 Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells J Clin Invest 112 1851 1861 doi:10.1172/JCI200319195
20. FC Yang S Chen T Clegg X Li T Morgan SA Estwick 2006 Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling Hum Mol Genet 15 2421 2437 doi:10.1093/hmg/ddl165
21. AS Kirshenbaum C Akin Y Wu M Rottem JP Goff MA Beaven 2003 Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI Leuk Res 27 677 682 doi:10.1016/S0145-2126(02)00343-0
22. L Kluwe RE Friedrich VF Mautner 1999 Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas Cancer Genet Cytogenet 113 65 69 doi:10.1016/S0165-4608(99)00006-0
23. H Kehrer-Sawatzki S Tinschert DE Jenne 2003 Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region J Med Genet 40 e116 doi:10.1136/jmg.40.10.e116
24. A Radonic S Thulke IM Mackay O Landt W Siegert A Nitsche 2004 Guideline to reference gene selection for quantitative real-time PCR Biochem Biophys Res Commun 313 856 862 doi:10.1016/j.bbrc.2003.11.177
25. RG Rutledge C Cote 2003 Mathematics of quantitative kinetic PCR and the application of standard curves Nucleic Acids Res 31 e93 doi:10.1093/nar/gng093
26. K Venkateswarlu KG Brandom H Yun 2007 PI-3-kinase-dependent membrane recruitment of centaurin-alpha2 is essential for its effect on ARF6-mediated actin cytoskeleton reorganisation J Cell Sci 120 792 801 doi:10.1242/jcs.03373
27. SE Tague V Muralidharan C D'Souza-Schorey 2004 ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway Proc Natl Acad Sci U S A 101 9671 9676 doi:10.1073/pnas.0403531101
28. AB Fielding E Schonteich J Matheson G Wilson X Yu GR Hickson 2005 Rab11-FIP3 and FIP4 interact with Arf6 and the exocyst to control membrane traffic in cytokinesis EMBO J 24 3389 3399 doi:10.1038/sj.emboj.7600803
29. V Piddubnyak P Rigou L Michel JC Rain O Geneste P Wolkenstein 2007 Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients Cell Death Differ 14 1222 1233 doi:10.1038/sj.cdd.4402122
30. M Lacroix SE Messaoudi G Rodier A Le Cam C Sardet E Fabbrizio 2008 The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5 EMBO Rep 9 452 458 doi:10.1038/embor.2008.45